Zivo Bioscience, Inc. SEC filings ZIVO
Zivo Bioscience, Inc. has 757 filings in SEC EDGAR's recent list, going back to Apr 20, 2000. Its latest annual report, Form ARS, was filed on Apr 25, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2025, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Mar 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 15, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 14, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | May 2, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Apr 22, 2022 | Dec 31, 2021 |
| 10-K/A | Amended annual report | Apr 30, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 25, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 26, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 12, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 21, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 31, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 29, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Apr 6, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 31, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 25, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 30, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Apr 15, 2011 | Dec 31, 2010 |
| 10-K | Annual report | Apr 14, 2010 | Dec 31, 2009 |
| 10-K | Annual report | May 18, 2009 | Dec 31, 2008 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZIVO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Bloomfield Hills, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1101026
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC (until Oct 16, 2014); WESTERN GLORY HOLE INC (until Jan 26, 2004)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.